Literature DB >> 26519350

Stability of Phosphatidylethanol in Dry Blood Spot Cards.

Ludmila N Bakhireva1, Shikhar Shrestha2, Hilda L Gutierrez2, Mike Berry3, Cheryl Schmitt2, Dusadee Sarangarm3.   

Abstract

BACKGROUND: The analysis of phosphatidylethanol, a promising direct ethanol metabolite, in dry blood spots (PEth-DBS) is advantageous due to ease of storage, transportation and minimal invasiveness of capillary blood collection. One potential application of PEth-DBS is to confirm prenatal alcohol exposure in newborns suspected of FASD; however, stability of PEth-DBS is largely unknown.
METHODS: Phlebotomized samples from 31 adults with a history of alcoholism, admitted to the University of New Mexico Emergency Department, were analyzed for blood alcohol content and pipetted onto DBS cards (13 spots per patient). The first spot was analyzed within 2 weeks of collection for a baseline PEth; the remaining 12 spots were allocated into three temperature conditions (room temperature, 4°C, -80°C) for the repeated measures analysis. In addition, 5 newborn DBS samples with a baseline PEth>LOD were obtained from a prospective cohort at UNM and re-analyzed at 4 months after storage at -80°C. A mixed linear model was fitted to examine the effects of temperature, time and temperature-time interaction on PEth degradation over the first 9 months.
RESULTS: The baseline PEth levels were 592.8 ± 86.7 ng/ml and 18.3 ± 4.8 ng/ml in adult and newborn samples, respectively. All DBS samples remained positive in successive samples in all temperature conditions. Results of mixed linear model demonstrated a significant effect of temperature (P < 0.001) on PEth degradation over 9 months.
CONCLUSIONS: PEth-DBS appears to be relatively stable, especially when stored at lower temperatures. These initial results are encouraging and highlight the PEth-DBS potential in retrospective assessment of alcohol exposure.
© The Author 2015. Medical Council on Alcohol and Oxford University Press. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26519350      PMCID: PMC4830409          DOI: 10.1093/alcalc/agv120

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  26 in total

1.  PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients.

Authors:  Steina Aradottir; Gulber Asanovska; Stefan Gjerss; Per Hansson; Christer Alling
Journal:  Alcohol Alcohol       Date:  2006-04-19       Impact factor: 2.826

2.  Prevalence and characteristics of fetal alcohol spectrum disorders.

Authors:  Philip A May; Amy Baete; Jaymi Russo; Amy J Elliott; Jason Blankenship; Wendy O Kalberg; David Buckley; Marita Brooks; Julie Hasken; Omar Abdul-Rahman; Margaret P Adam; Luther K Robinson; Melanie Manning; H Eugene Hoyme
Journal:  Pediatrics       Date:  2014-11       Impact factor: 7.124

3.  Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics.

Authors:  A Varga; P Hansson; G Johnson; C Alling
Journal:  Clin Chim Acta       Date:  2000-09       Impact factor: 3.786

4.  LC-MS/MS analysis of phosphatidylethanol in dried blood spots versus conventional blood specimens.

Authors:  Andrea Faller; Barbara Richter; Matthias Kluge; Patrick Koenig; Helmut K Seitz; Annette Thierauf; Heike Gnann; Michaela Winkler; Rainer Mattern; Gisela Skopp
Journal:  Anal Bioanal Chem       Date:  2011-07-09       Impact factor: 4.142

5.  Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin.

Authors:  Susanne Hartmann; Steina Aradottir; Marc Graf; Gerhard Wiesbeck; Otto Lesch; Katrin Ramskogler; Manfred Wolfersdorf; Christer Alling; Friedrich Martin Wurst
Journal:  Addict Biol       Date:  2007-03       Impact factor: 4.280

Review 6.  Biochemical markers of alcoholism.

Authors:  Minna L Hannuksela; Marja K Liisanantti; Antti E T Nissinen; Markku J Savolainen
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

7.  The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.

Authors:  Ludmila N Bakhireva; Renate D Savich; Dennis W Raisch; Sandra Cano; Robert D Annett; Lawrence Leeman; Mahek Garg; Chelsea Goff; Daniel D Savage
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

8.  Formation of phosphatidylethanol in vitro in red blood cells from healthy volunteers and chronic alcoholics.

Authors:  Arthur Varga; Christer Alling
Journal:  J Lab Clin Med       Date:  2002-08

9.  Time dependence of elimination of different PEth homologues in alcoholics in comparison with social drinkers.

Authors:  Heike Gnann; Annette Thierauf; Friedemann Hagenbuch; Bernhard Röhr; Wolfgang Weinmann
Journal:  Alcohol Clin Exp Res       Date:  2013-10-29       Impact factor: 3.455

10.  Ethanol, Neurodevelopment, Infant and Child Health (ENRICH) prospective cohort: Study design considerations.

Authors:  Ludmila N Bakhireva; Jean R Lowe; Hilda L Gutierrez; Julia M Stephen
Journal:  Adv Pediatr Res       Date:  2015-04-28
View more
  9 in total

1.  Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol use.

Authors:  Michael G McDonell; Jordan Skalisky; Emily Leickly; Michael F Orr; Sterling McPherson; John Roll; Nathalie Hill-Kapturczak; Martin Javors
Journal:  Psychol Addict Behav       Date:  2017-07-17

2.  Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking.

Authors:  Yan Wang; Xinguang Chen; Judith A Hahn; Babette Brumback; Zhi Zhou; Maria J Miguez; Robert L Cook
Journal:  Alcohol Clin Exp Res       Date:  2017-12-05       Impact factor: 3.455

3.  Phosphatidylethanol Detects Moderate-to-Heavy Alcohol Use in Liver Transplant Recipients.

Authors:  Michael Francis Fleming; Matthew J Smith; Erika Oslakovic; Michael R Lucey; Jenny X Vue; Patrice Al-Saden; Josh Levitsky
Journal:  Alcohol Clin Exp Res       Date:  2017-03-20       Impact factor: 3.455

4.  Use of alcohol biomarkers to identify alcohol misuse in organ donors.

Authors:  Erin M Lowery; Martin Walsh; Meagan Yong; Elizabeth J Kovacs; Cara Joyce; Majid Afshar
Journal:  Alcohol       Date:  2018-03-31       Impact factor: 2.405

Review 5.  Alcohol Biomarkers in Clinical and Forensic Contexts.

Authors:  Hilke Andresen-Streichert; Alexander Müller; Alexander Glahn; Gisela Skopp; Martina Sterneck
Journal:  Dtsch Arztebl Int       Date:  2018-05-04       Impact factor: 5.594

Review 6.  In utero alcohol effects on foetal, neonatal and childhood lung disease.

Authors:  Theresa W Gauthier; Lou Ann S Brown
Journal:  Paediatr Respir Rev       Date:  2016-08-19       Impact factor: 2.726

7.  Mixed-methods trial of a phosphatidylethanol-based contingency management intervention to initiate and maintain alcohol abstinence in formerly homeless adults with alcohol use disorders.

Authors:  Elizabeth R Fraser; Nathalie Hill-Kapturczak; Julianne Jett; Rachael Beck; Oladunni Oluwoye; Liat S Kriegel; Karl C Alcover; Sterling McPherson; Leopoldo J Cabassa; Martin Javors; Michael G McDonell
Journal:  Contemp Clin Trials Commun       Date:  2021-03-08

Review 8.  Biomarker-Based Approaches for Assessing Alcohol Use Disorders.

Authors:  Onni Niemelä
Journal:  Int J Environ Res Public Health       Date:  2016-01-27       Impact factor: 3.390

9.  DNA methylation signature on phosphatidylethanol, not on self-reported alcohol consumption, predicts hazardous alcohol consumption in two distinct populations.

Authors:  Xiaoyu Liang; Amy C Justice; Kaku So-Armah; John H Krystal; Rajita Sinha; Ke Xu
Journal:  Mol Psychiatry       Date:  2020-02-07       Impact factor: 13.437

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.